Abstract:OBJECTIVE:To investigate the effect of nano-TiO(2) intratracheal instillation on the progression of dyslipidemia and atherosclerosis in apolipoprotein E-knockout mice.METHODS:The nano-TiO(2) was ultrasound with phosphate-buffered saline solutions (PBS) into its suspension for exposure. A total of 46 specific pathogen free (SPF) level of 11-week-old male apolipoprotein E-knockout mice were randomly divided into groups by their body weights: non-treatment group (8 mice), PBS control group (9 mice), high dose group (1.0 mg/ml, 10 mice), medium dose group (0.5 mg/ml, 10 mice), and low dose group (0.1 mg/ml, 9 mice). Except the non-treatment group, mice from other groups were intratracheally instilled with 0.05 ml each time, twice a week. After exposure of 6 weeks, viscera index, blood TC, TG, HDL-C, LDL-C, and organic lipid ratio were assessed as biomarkers. Artery and aortic root issues were assessed by histopathology.RESULTS:After 5 weeks exposure, mice body weights in high dose group ((29.7 ± 1.9) g) started to drop, compared to PBS control ((31.3 ± 1.9) g, t = -1.58, P < 0.05) and low dose group ((31.4 ± 1.4) g, t = -1.17, P < 0.05); after 6 weeks, high dose group ((28.8 ± 1.5) g) was lower than PBS control ((30.4 ± 1.9) g, t = -1.60, P < 0.05), non-treatment group ((30.2 ± 1.3) g, t = -1.43, P < 0.05) and low dose group ((30.6 ± 1.0) g, t = -1.83, P < 0.05). TC levels of non-treatment, PBS control, high dose group, medium dose group and low dose group were (2.92 ± 1.18), (3.12 ± 0.73), (4.19 ± 1.86), (3.46 ± 0.72) and (2.57 ± 0.64) mmol/L, respectively; TG levels were (0.39 ± 0.13), (0.39 ± 0.08), (0.60 ± 0.21), (0.55 ± 0.19) and (0.41 ± 0.11) mmol/L, respectively; HDL-C levels were (1.67 ± 0.45), (1.54 ± 0.67), (0.93 ± 0.50), (1.02 ± 0.48) and (1.31 ± 0.64) mmol/L; TG levels of high dose group were higher than that of non-treatment group (t = 1.27, P = 0.03) and low dose group (t = 1.62, P = 0.01); TG levels of medium dose group was higher than PBS control (t = 0.16, P = 0.04), and TC levels of high dose group were higher than PBS control (t = 0.22, P = 0.01), non-treatment group (t = 0.22, P = 0.04) and low dose group (t = 0.20, P = 0.03), and HDL-C levels of high dose group were lower than PBS control (t = -0.61, P = 0.04) and non-treatment group (t = -0.74, P = 0.04); organic lipid ratio of each group were (2.27 ± 0.51)%, (2.06 ± 0.53)%, (2.90 ± 0.50)%, (2.60 ± 0.23)%, (2.24 ± 0.45)%; high dose group were higher than PBS control (t = 0.85, P = 0.00), non-treatment group (t = 0.64, P = 0.03) and low dose group (t = 0.67, P = 0.01); medium dose group was higher than PBS control (t = 0.54, P = 0.02). The plaque lipid content and calcium content which showed the progression of atherosclerosis and plaque rupture were elevated in medium and high dose groups.CONCLUSION:Intratracheal instillation of nano-TiO(2) can induce dyslipidemia and accelerate the development of atherosclerosis and plaque rupture in ApoE-/-mice.

Cardiovascular Effects of Pulmonary Exposure to Titanium Dioxide Nanoparticles in ApoE Knockout Mice.

[Effect of Nano-Tio(2) Intratracheal Instillation on Lipid Metabolism of AopE Gene-Knockout Mice].

Changes of Serum Parameters of Tio2 Nanoparticle-Induced Atherosclerosis in Mice

Cardiac oxidative damage in mice following exposure to nanoparticulate titanium dioxide.

Pulmotoxicological Effects Caused by Long-Term Titanium Dioxide Nanoparticles Exposure in Mice.

Effect of Titanium Dioxide Nanoparticles on the Cardiovascular System after Oral Administration

Immune Toxicity Of Small Size Titanium Dioxide Nanoparticles On Rats Pulmonary Alveolar Macrophages Via Intra-Tracheal Instillation In Vivo

Pulmonary Toxicity Induced by Three Forms of Titanium Dioxide Nanoparticles Via Intra-Tracheal Instillation in Rats

In Vivo Acute Toxicity of Titanium Dioxide Nanoparticles to Mice after Intraperitioneal Injection

Toxicological Characteristics of Titanium Dioxide Nanoparticle in Rats

Bio-Effects of Nano-Titanium Dioxide on Lungs of Mice

Aerosol Inhalation Exposure Study of Respiratory Toxicity Induced by 20 Nm Anatase Titanium Dioxide Nanoparticles

Cardiopulmonary Effects Induced by Occupational Exposure to Titanium Dioxide Nanoparticles.

Oxidative Damage of Lung and Its Protective Mechanism in Mice Caused by Long-Term Exposure to Titanium Dioxide Nanoparticles.

Cardiac Inflammation Involving In Pkc Epsilon Or Erk1/2-Activated Nf-Kappa B Signalling Pathway In Mice Following Exposure To Titanium Dioxide Nanoparticles

Heterogeneous Vascular Bed Responses to Pulmonary Titanium Dioxide Nanoparticle Exposure

Systemic Immune Effects of Titanium Dioxide Nanoparticles after Repeated Intratracheal Instillation in Rat

Effects of Fine Particulate Matter (PM2.5) on Systemic Oxidative Stress and Cardiac Function in ApoE−/− Mice

Effects Of Fine Particulate Matter (Pm2.5) On Systemic Oxidative Stress And Cardiac Function In Apoe(-/-) Mice

The Potential Liver, Brain, and Embryo Toxicity of Titanium Dioxide Nanoparticles on Mice

Acute Toxicity of Intravenously Administered Titanium Dioxide Nanoparticles in Mice